COMPARATIVE THERAPEUTIC’S EFFECT OF CLOZAPINE AND RISPERIDONE IN THE DRUG RESISTANT SCHIZOPHRENIA

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

SHAKIBA MANSOUR

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Internal Medicine Today Year:2005 | Volume:11 | Issue:2 Page(s): 41-44

Download Full-Text

Persian Verion

View:

2,439

Download:

Cites:

Information Journal Paper

Title

COMPARATIVE THERAPEUTIC’S EFFECT OF CLOZAPINE AND RISPERIDONE IN THE DRUG RESISTANT SCHIZOPHRENIA

Author(s)

SHAKIBA MANSOUR | Issue Writer Certificate

Keywords

CLOZAPINEQ4

RISPRIDONEQ3

DRUG RESISTANT SCHIZOPHRENIAQ3

Abstract

Background and Aim: Schizophrenia has a prevalence of 1% and accounts for 2.5% of heath-care in USA. FDA has approved the drug CLOZAPINE for treatment of drug resistant forms of schizophrenia. The aim of this study was the comparative therapeutic’s effect of CLOZAPINE and risperidone in the DRUG RESISTANT SCHIZOPHRENIA .Materials and Methods: In this cross-sectional study therapeutic effect of two different drugs CLOZAPINE and RISPRIDONE have been compared on 40 drug resistant male and female schizophrenia cases admitted in Rehabilitation Center of Chronic Mental Diseases of Zahedan Welfare Organization in Iran. Patients were divided in two groups for treatment with either CLOZAPINE or RISPRIDONE. The patient’s improvement was evaluated with clinical interviews and BPRS tests. The data was analyzed by Chi-Square and t-test variance analysis.Results: Initial BPRS results was determined as an average of 52.80±7.70 for CLOZAPINE group and average of 49.80±5.98 for RISPRIDONE group. Three month after start of treatment average of BPRS and SD was 22.95, 1.57, 24.53 for CLOZAPINE group, and 2.49 for RISPRIDONE group respectively . The average decrease in BPRS was calculated as 29.58±7.08 for CLOZAPINE and 25.49±5.94 for RISPRIDONE. The statistical markers were determined as P=0.48 and t-test=-2.13.Conclusion: The results confirm that CLOZAPINE acted more effectively than RISPRIDONE and has been tolerated by the patients.

Cites

No record.

References

PREVALENCE OF SEIZURE AMONG PATIENTS UNDER CLOZAPINE TREATMENT IN SHAHID ESMA’ILI PSYCHIATRIC CENTER

Cite

APA: Copy

SHAKIBA, MANSOUR. (2005). COMPARATIVE THERAPEUTIC’S EFFECT OF CLOZAPINE AND RISPERIDONE IN THE DRUG RESISTANT SCHIZOPHRENIA. OFOGH-E-DANESH, 11(2), 41-44. SID. https://sid.ir/paper/385063/en

Vancouver: Copy

SHAKIBA MANSOUR. COMPARATIVE THERAPEUTIC’S EFFECT OF CLOZAPINE AND RISPERIDONE IN THE DRUG RESISTANT SCHIZOPHRENIA. OFOGH-E-DANESH[Internet]. 2005;11(2):41-44. Available from: https://sid.ir/paper/385063/en

IEEE: Copy

MANSOUR SHAKIBA, “COMPARATIVE THERAPEUTIC’S EFFECT OF CLOZAPINE AND RISPERIDONE IN THE DRUG RESISTANT SCHIZOPHRENIA,” OFOGH-E-DANESH, vol. 11, no. 2, pp. 41–44, 2005, [Online]. Available: https://sid.ir/paper/385063/en

Related Journal Papers